Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

24.75
+0.15000.61%
Post-market: 24.750.00000.00%16:20 EDT
Volume:189.40K
Turnover:4.66M
Market Cap:680.65M
PE:-9.21
High:25.47
Open:24.52
Low:23.64
Close:24.60
Loading ...

Company Profile

Company Name:
Therapeutics
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
445 Marine View Avenue,Suite 320,Del Mar,California,United States
Zip Code:
92014
Fax:
- -
Introduction:
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.

Directors

Name
Position
Josh Lehrer
President, Chief Executive Officer and Director
Perry Karsen
Director and Board Chair
Abraham Bassan
Director
Carlo Rizzuto
Director
Jerel Davis
Director
Jo Viney
Director
Joseph Jimenez
Director
Kristen M. Hege
Director
Matthew Porteus
Director
Smital Shah
Director

Shareholders

Name
Position
Josh Lehrer
President, Chief Executive Officer and Director
Alethia Young
Chief Financial Officer